Genetic Tumor Testing
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
A new program at Massachusetts General Hospital in Boston includes extracting the DNA from its cancer patients’ tumors to determine which abnormalities occur in the tumor cells, specific to the type of tumor. From these results, physicians hope to create better, targeted cancer therapies. Host Dr. Lee Freedman asks Dr. Leif Ellisen, associate professor of medicine at Harvard Medical School, about the details of this program. Will genetic tumor profiling be conducted at many more cancer centers in the near future?
Overview
A new program at Massachusetts General Hospital in Boston includes extracting the DNA from its cancer patients’ tumors to determine which abnormalities occur in the tumor cells, specific to the type of tumor. From these results, physicians hope to create better, targeted cancer therapies. Host Dr. Lee Freedman asks Dr. Leif Ellisen, associate professor of medicine at Harvard Medical School, about the details of this program. Will genetic tumor profiling be conducted at many more cancer centers in the near future?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Updates From the 7th World Symposium Task Force
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?